Design, synthesis, and evaluation of phenylpiperazine-phenylacetate derivatives as rapid recovery hypnotic agents

Bioorg Med Chem Lett. 2022 Feb 1:57:128497. doi: 10.1016/j.bmcl.2021.128497. Epub 2021 Dec 8.

Abstract

In this paper, we designed and synthesized a series of novel phenylpiperazine-phenylacetate derivatives as rapid recovery hypnotic agents. The best compound 10 had relatively high affinity for the GABAA receptor and low affinity for thirteen other off-target receptors. In three animal models (mice, rats, and rabbits), compound 10 exerted potent hypnotic effects (HD50 = 5.2 mg/kg in rabbits), comparable duration of the loss of righting reflex (LORR), and significant shorter recovery time (time to walk) than propanidid. Furthermore, compound 10 (TI = 18.1) showed higher safety profile than propanidid (TI = 14.7) in rabbits. Above results suggested that compound 10 may have predictable and rapid recovery profile in anesthesia.

Keywords: Anesthetic; Hypnotic agents; Phenylacetate derivatives; Phenylpiperazine.

MeSH terms

  • Animals
  • Drug Design
  • Guinea Pigs
  • Hypnotics and Sedatives / chemical synthesis
  • Hypnotics and Sedatives / metabolism
  • Hypnotics and Sedatives / pharmacology*
  • Male
  • Mice
  • Phenylacetates / chemical synthesis
  • Phenylacetates / metabolism
  • Phenylacetates / pharmacology*
  • Piperazines / chemical synthesis
  • Piperazines / metabolism
  • Piperazines / pharmacology*
  • Rabbits
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, GABA-A / metabolism

Substances

  • Hypnotics and Sedatives
  • Phenylacetates
  • Piperazines
  • Receptors, GABA-A